Clinical trial

Amlodipine as add-on to Olmesartan in Hypertension

NCT00220220

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-04-01

PhasePHASE3

Study timeline

Study start (unknown)2005-04-01Date precision: month

Registry last updated2018-12-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Essential Hypertensionunresolved

Interventions

olmesartan medoxomilDRUG · verified · RxNorm: olmesartan medoxomil

amlodipineDRUG · verified · RxNorm: amlodipine

Sponsors & collaborators

Sankyo Pharma Gmbhlead sponsor

Mapped research locations

HamburgGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00220220 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.